Oticara Inc is a clinical stage pharmaceutical company based in Austin, TX, dedicated to improving the quality of life for patients with sinus and ear conditions. They focus on developing innovative treatments for sinusitis and otitis externa, aiming to provide effective solutions for patients who have not achieved complete symptom resolution through existing therapies or surgery.
With a team of experienced pharmaceutical development executives, Oticara is committed to advancing their pipeline of treatments, including a patented sinusitis treatment for patients who have undergone functional endoscopic sinus surgery (FESS) and a one-time, in-office treatment for bacterial and fungal pathogens causing otitis externa infections of the outer ear. Their clinical studies have shown promising results, and further research is planned to validate the efficacy of their treatments.
Generated from the website